Increxxa™ (tulathromycin injection)
Increxxa™ (tulathromycin injection)
Increxxa™ contains tulathromycin, the same macrolide antibiotic veterinarians and the cattle industry have depended on to control and treat bovine respiratory disease (BRD) in cattle for more than 15 years. It’s a go-to antibiotic for beef and dairy producers because of its one-time use, extended duration of action, ease of administration and broad-spectrum control.
Weight
100mL, 250mL, 500mL
N/A
Dosage
1.1 ml / 100 lbs
Key Product Benefits:
- Delivers a broad BRD solution for customers.
- Healthier cattle and an improved bottom line.
- Supported by Elanco's antibiotic stewardship initiatives.
- Part of Elanco's comprehensive BRD portfolio.
Control and Treat BRD With Lasting Confidence
BRD is a complex respiratory disease in cattle that costs producers across the industry an average of $3 billion annually.1,2,3 It can be brought on by a variety of physical and physiological stressors. These include weaning, age, undernutrition, parasitism, handling, dust, acidosis, commingling, transportation, time, weather and vaccination status, which make it incredibly difficult to control and lead to death.
Balance your BRD protocol and budget with Increxxa, which combines the proven performance of tulathromycin with quality manufacturing from Elanco. With Increxxa, producers and veterinarians get a macrolide antibiotic they depend on at a better value. It’s also labeled for the treatment of pinkeye and footrot, giving them one more reason to choose it as a cattle health solution.
Quickly targets site of infection in lungs and circulates rapidly for early BRD control.⁴
Gives more time to bolster an effective defense.⁴
Reduces return trips to the hospital pen and gets healthy cattle back to the feedbunk.⁴
Manufactured with Elanco’s uncompromising standard for potency, uniformity and quality.
* Clinical relevance unknown.
Important Product Information
Learn more about how to properly administer, store and use Increxxa. See label for complete use guidelines, including all cautions and warnings. Always read, understand and follow the label and use directions.
Indications
Cautions
Storage
Administration
Indications
Beef and Non-Lactating Dairy Cattle: Treatment of bovine respiratory disease (BRD) and control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Treatment of infectious bovine keratoconjunctivitis (IBK) associated with M. bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with F. necrophorum and P. levii.
Suckling Calves, Dairy Calves and Veal Calves: Treatment of BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
Increxxa Product Information
Click to download Increxxa Product Label.
Click to download Increxxa Beef Product Brochure.
Click to download Increxxa Technical Sheet.
The label contains complete use information, including cautions and warnings. Always read, understand and follow the label, and use directions.
Increxxa
Cautions:
Not for human use. Keep out of reach of children. Do not use in animals previously found to be hypersensitive to the drug. Increxxa has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older.
Indications:
Beef and Non-Lactating Dairy Cattle: Treatment of bovine respiratory disease (BRD) and control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Treatment of infectious bovine keratoconjunctivitis (IBK) associated with M. bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with F. necrophorum and P. levii.
Suckling Calves, Dairy Calves and Veal Calves: Treatment of BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
Directions for use:
In cattle, inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight. Do not inject more than 10 mL per injection site.
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Extra-label use of this drug in food-producing animals is prohibited. Cattle intended for human consumption must not be slaughtered within 18 days from the last treatment. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
Increxxa, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.